Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.52
-0.59 (-5.84%)
At close: Feb 21, 2025, 4:00 PM
9.83
+0.31 (3.26%)
After-hours: Feb 21, 2025, 4:35 PM EST
Immunome Employees
Immunome had 55 employees as of December 31, 2023. The number of employees increased by 18 or 48.65% compared to the previous year.
Employees
55
Change (1Y)
18
Growth (1Y)
48.65%
Revenue / Employee
$184,164
Profits / Employee
-$5,551,782
Market Cap
778.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | 39 | 16 | 69.57% |
| Dec 31, 2020 | 23 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
IMNM News
- 16 days ago - Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 22 days ago - Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Business Wire
- 23 days ago - Immunome Can Take The Fight To Competitors With Varegacestat - Seeking Alpha
- 23 days ago - Immunome Announces Pricing of Upsized Public Offering of Common Stock - Business Wire
- 24 days ago - Immunome Announces Proposed Public Offering of Common Stock - Business Wire
- 5 weeks ago - Immunome Provides Pipeline Update in Advance of Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 3 months ago - Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 3 months ago - Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire